levamisole has been researched along with Lichen Planus, Oral in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 6 (46.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, TF; Lin, CJ; Lu, SY | 1 |
Chen, HM; Chia, JS; Lin, HP; Sun, A; Wang, YP; Wu, KM | 1 |
Chia, JS; Chiang, CP; Lin, HP; Sun, A; Wang, YP | 1 |
Chia, JS; Lin, HP; Sun, A; Wang, YP | 2 |
Chiang, CP | 1 |
Chia, JS; Chiang, CP; Sun, A; Wang, JT | 2 |
Chiang, CP; Chiou, PS; Liu, BY; Sun, A; Wang, JT; Wu, YC | 1 |
Chen, WJ; Eng, HL; Lu, SY | 2 |
Chiang, CP; Sun, A | 1 |
Chang, YF; Chia, JS; Chiang, CP; Sun, A | 1 |
4 trial(s) available for levamisole and Lichen Planus, Oral
Article | Year |
---|---|
Modulation of serum gastric parietal cell antibody level by levamisole and vitamin B12 in oral lichen planus.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Anemia, Pernicious; Autoantibodies; Case-Control Studies; Female; Gastritis, Atrophic; Humans; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Parietal Cells, Gastric; Reference Values; Vitamin B 12; Vitamin B Complex; Young Adult | 2011 |
Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunologic Factors; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Prednisolone; Prospective Studies; Treatment Outcome | 1995 |
Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study.
Topics: Adjuvants, Immunologic; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Drug Combinations; Erythema Multiforme; Female; Follow-Up Studies; Humans; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Oral Ulcer; Pemphigoid, Benign Mucous Membrane; Pemphigus; Prednisolone; Treatment Outcome | 1998 |
Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus.
Topics: Adjuvants, Immunologic; Antigens, Neoplasm; Astragalus propinquus; Biomarkers, Tumor; Carcinoma, Squamous Cell; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Levamisole; Lichen Planus, Oral; Mouth Neoplasms; Phytotherapy; Plants, Medicinal; Serpins | 2001 |
9 other study(ies) available for levamisole and Lichen Planus, Oral
Article | Year |
---|---|
Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Agranulocytosis; Female; Humans; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Pancytopenia; Prednisolone; Treatment Outcome | 2019 |
Modulation of serum smooth muscle antibody levels by levamisole treatment in patients with oral lichen planus.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Autoantibodies; Female; Humans; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Muscle, Smooth | 2013 |
Modulation of serum anti-thyroglobulin and anti-thyroid microsomal autoantibody levels by levamisole in patients with oral lichen planus.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Autoantibodies; Humans; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Young Adult | 2011 |
Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Female; Fluorescent Antibody Technique, Indirect; Humans; Levamisole; Lichen Planus, Oral; Male; Middle Aged | 2011 |
Levamisole is an effective immunomodulator for patients with oral lichen planus.
Topics: Adjuvants, Immunologic; Humans; Immunomodulation; Levamisole; Lichen Planus, Oral; Treatment Outcome | 2012 |
Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
Topics: Acute Disease; Adult; Aged; Analysis of Variance; Biomarkers; Female; Humans; Immunologic Factors; Interleukin-6; Interleukin-8; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Mouth Mucosa; Sensitivity and Specificity | 2005 |
Levamisole can reduce the high serum tumour necrosis factor-alpha level to a normal level in patients with erosive oral lichen planus.
Topics: Adjuvants, Immunologic; Humans; Levamisole; Lichen Planus, Oral; Tumor Necrosis Factor-alpha | 2007 |
Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Antigen-Antibody Complex; Case-Control Studies; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Child; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Stomatitis, Aphthous; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer | 1994 |
Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Astragalus propinquus; Biomarkers; Drug Combinations; Drugs, Chinese Herbal; Erythema Multiforme; Female; Follow-Up Studies; Humans; Interleukin-6; Levamisole; Lichen Planus, Oral; Luminescent Measurements; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Oral Submucous Fibrosis; Oral Ulcer; Pemphigus; Phytotherapy; Sjogren's Syndrome; Statistics as Topic | 2002 |